These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6428401)

  • 1. Inactivation of glucosamine-6-phosphate synthetase from Salmonella typhimurium LT 2 SL 1027 by N beta-fumarylcarboxyamido-L-2,3-diamino-propionic acid.
    Chmara H; Andruszkiewicz R; Borowski E
    Biochem Biophys Res Commun; 1984 May; 120(3):865-72. PubMed ID: 6428401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of glucosamine-6-phosphate synthetase from Salmonella typhimurium LT2 by fumaroyl diaminopropanoic acid derivatives, a novel group of glutamine analogs.
    Chmara H; Andruszkiewicz R; Borowski E
    Biochim Biophys Acta; 1986 Mar; 870(2):357-66. PubMed ID: 3082365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic derivatives of N3-fumaroyl-L-2,3-diaminopropanoic acid inactivate glucosamine synthetase from Candida albicans.
    Milewski S; Chmara H; Andruszkiewicz R; Borowski E
    Biochim Biophys Acta; 1985 Apr; 828(3):247-54. PubMed ID: 3921053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucosamine synthetase from Escherichia coli: kinetic mechanism and inhibition by N3-fumaroyl-L-2,3-diaminopropionic derivatives.
    Badet B; Vermoote P; Le Goffic F
    Biochemistry; 1988 Apr; 27(7):2282-7. PubMed ID: 3132968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of N3-fumaramoyl-L-2,3-diaminopropanoic acid analogues, the irreversible inhibitors of glucosamine synthetase.
    Andruszkiewicz R; Chmara H; Milewski S; Borowski E
    Int J Pept Protein Res; 1986 May; 27(5):449-53. PubMed ID: 3089958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticapsin, an active-site directed irreversible inhibitor of glucosamine-6-phosphate synthetase from Escherichia coli.
    Chmara H; Zähner H; Borowski E
    J Antibiot (Tokyo); 1984 Sep; 37(9):1038-43. PubMed ID: 6389459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of glucosamine-6-phosphate synthetase from bacteria by anticapsin.
    Chmara H; Zähner H; Borowski E; Milewski S
    J Antibiot (Tokyo); 1984 Jun; 37(6):652-8. PubMed ID: 6430854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucosamine-6-phosphate synthase from Escherichia coli: determination of the mechanism of inactivation by N3-fumaroyl-L-2,3-diaminopropionic derivatives.
    Kucharczyk N; Denisot MA; Le Goffic F; Badet B
    Biochemistry; 1990 Apr; 29(15):3668-76. PubMed ID: 2111163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glucosamine synthase by bacilysin and anticapsin.
    Chmara H
    J Gen Microbiol; 1985 Feb; 131(2):265-71. PubMed ID: 3884731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticandidal properties of N3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid oligopeptides.
    Andruszkiewicz R; Milewski S; Zieniawa T; Borowski E
    J Med Chem; 1990 Jan; 33(1):132-5. PubMed ID: 2104933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inactivation of glucosamine synthetase from bacteria by anticapsin, the C-terminal epoxyamino acid of the antibiotic tetaine.
    Chmara H; Zähner H
    Biochim Biophys Acta; 1984 May; 787(1):45-52. PubMed ID: 6426523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific inhibition of acid proteinase secretion in Candida albicans by Lys-Nva-FMDP.
    Milewski S; Mignini F; Covelli I; Borowski E
    J Med Vet Mycol; 1994; 32(1):1-11. PubMed ID: 8207618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal peptides with novel specific inhibitors of glucosamine 6-phosphate synthase.
    Milewski S; Chmara H; Andruszkiewicz R; Borowski E; Zaremba M; Borowski J
    Drugs Exp Clin Res; 1988; 14(7):461-5. PubMed ID: 3149235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N3-haloacetyl derivatives of L-2,3-diaminopropanoic acid: novel inactivators of glucosamine-6-phosphate synthase.
    Milewski S; Chmara H; Andruszkiewicz R; Borowski E
    Biochim Biophys Acta; 1992 Jan; 1115(3):225-9. PubMed ID: 1739736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucosamine-6-phosphate synthase, a novel target for antifungal agents. Molecular modelling studies in drug design.
    Wojciechowski M; Milewski S; Mazerski J; Borowski E
    Acta Biochim Pol; 2005; 52(3):647-53. PubMed ID: 16082410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, anticandidal activity of N(3)-(4-methoxyfumaroyl)-(S)-2,3-diaminopropanoic amide derivatives--novel inhibitors of glucosamine-6-phosphate synthase.
    Pawlak D; Stolarska M; Wojciechowski M; Andruszkiewicz R
    Eur J Med Chem; 2015 Jan; 90():577-82. PubMed ID: 25497131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amide and ester derivatives of N3-(4-methoxyfumaroyl)-(S)-2,3-diaminopropanoic acid: the selective inhibitor of glucosamine-6-phosphate synthase.
    Zgódka D; Jedrzejczak R; Milewski S; Borowski E
    Bioorg Med Chem; 2001 Apr; 9(4):931-8. PubMed ID: 11354676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the inhibition pathway of glucosamine synthase by N3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid by semiempirical quantum mechanical and molecular mechanics methods.
    Tarnowska M; Oldziej S; Liwo A; Grzonka Z; Borowski E
    Eur Biophys J; 1992; 21(4):273-80. PubMed ID: 1425480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constrained search of conformational hyperspace of inactivators of glucosamine-6-phosphate synthase.
    Wojciechowski M; Mazerski J; Borowski E
    J Enzyme Inhib; 1996; 10(1):17-26. PubMed ID: 8835927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticapsin: an active site directed inhibitor of glucosamine-6-phosphate synthetase from Candida albicans.
    Milewski S; Chmara H; Borowski E
    Drugs Exp Clin Res; 1986; 12(6-7):577-83. PubMed ID: 3527630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.